We previously demonstrated the ability of the Cp 010904 strain and CP-derived BLPs to beneficially modulate the respiratory innate immunity against pneumococcal infection by evaluating immunological parameters at 2 days post-infection [10,11]. The gene discussed is CP; the disease is pneumococcal infection.